174 related articles for article (PubMed ID: 14725677)
1. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.
Carroll PV; Monson JP; Grossman AB; Besser GM; Plowman PN; Afshar F; Savage MO
Clin Endocrinol (Oxf); 2004 Feb; 60(2):169-74. PubMed ID: 14725677
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone status following treatment for Cushing's syndrome.
Hughes NR; Lissett CA; Shalet SM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
[TBL] [Abstract][Full Text] [Related]
3. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
4. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.
Savage MO; Lienhardt A; Lebrethon MC; Johnston LB; Huebner A; Grossman AB; Afshar F; Plowman PN; Besser GM
Horm Res; 2001; 55 Suppl 1():24-30. PubMed ID: 11408758
[TBL] [Abstract][Full Text] [Related]
5. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood [see comment].
Nicolson A; Toogood AA; Rahim A; Shalet SM
Clin Endocrinol (Oxf); 1996 Mar; 44(3):311-6. PubMed ID: 8729528
[TBL] [Abstract][Full Text] [Related]
7. Linear growth and final height after treatment for Cushing's disease in childhood.
Lebrethon MC; Grossman AB; Afshar F; Plowman PN; Besser GM; Savage MO
J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
[TBL] [Abstract][Full Text] [Related]
8. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
[TBL] [Abstract][Full Text] [Related]
9. Growth in disorders of adrenal hyperfunction.
Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
[TBL] [Abstract][Full Text] [Related]
10. Growth and growth hormone secretion in paediatric Cushing's disease.
Savage MO; Storr HL; Grossman AB; Krassas GE
Hormones (Athens); 2003; 2(2):93-7. PubMed ID: 17003007
[TBL] [Abstract][Full Text] [Related]
11. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status.
Toogood AA; Ryder WD; Beardwell CG; Shalet SM
Clin Endocrinol (Oxf); 1995 Jul; 43(1):97-103. PubMed ID: 7641416
[TBL] [Abstract][Full Text] [Related]
12. Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Tzanela M; Karavitaki N; Stylianidou C; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2004 Mar; 60(3):309-14. PubMed ID: 15008995
[TBL] [Abstract][Full Text] [Related]
13. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
[TBL] [Abstract][Full Text] [Related]
14. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.
Magiakou MA; Mastorakos G; Gomez MT; Rose SR; Chrousos GP
J Clin Endocrinol Metab; 1994 Jan; 78(1):131-7. PubMed ID: 7507118
[TBL] [Abstract][Full Text] [Related]
15. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
[TBL] [Abstract][Full Text] [Related]
16. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
[TBL] [Abstract][Full Text] [Related]
17. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome.
Leal-Cerro A; Venegas E; Garcia-Pesquera F; Jimenez LM; Astorga R; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1998 Jan; 48(1):117-21. PubMed ID: 9509077
[TBL] [Abstract][Full Text] [Related]
18. Final adult height and body mass index after cure of paediatric Cushing's disease.
Davies JH; Storr HL; Davies K; Monson JP; Besser GM; Afshar F; Plowman PN; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2005 Apr; 62(4):466-72. PubMed ID: 15807878
[TBL] [Abstract][Full Text] [Related]
19. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
Pfeifer M; Kanc K; Verhovec R; Kocijancic A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
